Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × Oxycodone × Clear all

Sponsor

Conditions

Neoplasms 5 Cancer Pain 4 Pain 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Malignant Neoplasms of Female Genital Organs 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1

Interventions

Prednisone 90 Docetaxel 77 Leuprolide 68 enzalutamide 56 Abiraterone Acetate 55 bicalutamide 40 Goserelin 40 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 36 Radiotherapy 30 abiraterone 20 apalutamide 19 sipuleucel-T 18 luprolide acetate gel depot 18 gallium 68 PSMA-11 18 Gonadotropin-Releasing Hormone 18 Radiosurgery 16 Magnetic Resonance Spectroscopy 16 Triptorelin Pamoate 15 Androgen Antagonists 15 cabazitaxel 14 Radiotherapy, Intensity-Modulated 13 pembrolizumab 12 Prednisolone 12 Dexamethasone 12 Brachytherapy 12 cabozantinib 11 Radiation 11 Dutasteride 11 Carboplatin 11 radium Ra 223 dichloride 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡